A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia

NCT00515034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia, Ventilator-Associated
Pneumonia, Bacterial
Pneumonia
Abdominal Abscess
Bacterial Infections

Interventions

DRUG: Imipenem/cilastatin
DRUG: Imipenem/cilastatin
DRUG: Doripenem
DRUG: Doripenem

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.